These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20868273)

  • 1. Strategies to discover unexpected targets for drugs active at G protein-coupled receptors.
    Allen JA; Roth BL
    Annu Rev Pharmacol Toxicol; 2011; 51():117-44. PubMed ID: 20868273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based assays in GPCR drug discovery.
    Siehler S
    Biotechnol J; 2008 Apr; 3(4):471-83. PubMed ID: 18383022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM; Bosse R; Reisine T
    Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled receptors: novel targets for drug discovery in cancer.
    Lappano R; Maggiolini M
    Nat Rev Drug Discov; 2011 Jan; 10(1):47-60. PubMed ID: 21193867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
    Sriram K; Insel PA
    Mol Pharmacol; 2018 Apr; 93(4):251-258. PubMed ID: 29298813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Approaches for the Discovery of GPER Targeting Compounds.
    Grande F; Occhiuzzi MA; Lappano R; Cirillo F; Guzzi R; Garofalo A; Jacquot Y; Maggiolini M; Rizzuti B
    Front Endocrinol (Lausanne); 2020; 11():517. PubMed ID: 32849301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.
    Gruber CW; Muttenthaler M; Freissmuth M
    Curr Pharm Des; 2010; 16(28):3071-88. PubMed ID: 20687879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using silico methods predicting ligands for orphan GPCRs.
    Jiang Z; Zhou Y
    Curr Protein Pept Sci; 2006 Oct; 7(5):459-64. PubMed ID: 17073696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational studies to predict or explain G protein coupled receptor polypharmacology.
    Jacobson KA; Costanzi S; Paoletta S
    Trends Pharmacol Sci; 2014 Dec; 35(12):658-63. PubMed ID: 25458540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological relevance of GPCR oligomerization and its impact on drug discovery.
    Panetta R; Greenwood MT
    Drug Discov Today; 2008 Dec; 13(23-24):1059-66. PubMed ID: 18824244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoproteomic Approach to Explore the Target Profile of GPCR ligands: Application to 5-HT1A and 5-HT6 Receptors.
    Gamo AM; González-Vera JA; Rueda-Zubiaurre A; Alonso D; Vázquez-Villa H; Martín-Couce L; Palomares Ó; López JA; Martín-Fontecha M; Benhamú B; López-Rodríguez ML; Ortega-Gutiérrez S
    Chemistry; 2016 Jan; 22(4):1313-21. PubMed ID: 26560738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical guide for calculating and representing biased signaling by GPCR ligands: A stepwise approach.
    Nagi K; Pineyro G
    Methods; 2016 Jan; 92():78-86. PubMed ID: 26364590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing biased responses of GPCR ligands.
    Benredjem B; Dallaire P; Pineyro G
    Curr Opin Pharmacol; 2017 Feb; 32():71-76. PubMed ID: 27930943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs).
    Wang D; Li Y; Zhang Y; Liu Y; Shi G
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):232-41. PubMed ID: 22221056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Web-Based Tools for Polypharmacology Prediction.
    Awale M; Reymond JL
    Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.